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Background
Mucopolysaccharidosis (MPS) are a group of rare inher-
ited metabolic disorders which are caused due to the
deficiency of a specific lysosomal enzyme involved in
the catabolism of glycosaminoglycans. These disorders
show a wide clinical spectrum ranging from severe,
intermediate and mild phenotypes. Most of them show
overlapping clinical features such as corneal clouding,
coarse facies, hepatosplenomegaly, skeletal dysplasia,
short stature, dysostosis multiplex, joint stiffness, joint
contractures, cardiovascular and respiratory difficulties.
Certain MPS disorders also show impaired neurological
functions leading to mental retardation. They are inherited
as an autosomal recessive with exception of MPS II, which
is X-linked recessive disorder. They exhibit clinical, genetic
as well as molecular heterogeneity. To date more than 200
mutations in IDUA, ~ 500 in IDS, ~ 200 in GALNS and
~ 200 in ARSB have been reported worldwide. The muta-
tion spectrum of MPS disorders in Indian population is
not characterized and established yet. This study was done
to establish mutation spectrum in the Indian population
that can be useful for the design of cost-effective strategies
towards the molecular diagnosis of MPS disorders.
Materials and Methods
We have carried out mutation analysis of a total of 90 dif-
ferent MPS disorder patients (MPS I, II, IV and VI) and
identified a total of 64 different mutations comprising
majorly missense, nonsense, small deletions and splice site
mutations. The mutations were further characterized
using mutation prediction software and protein structure
analysis for pathogenicity prediction.
Conclusion
The characterization of mutational spectrum of Indian
patients is likely to be useful in provision of better carrier
diagnosis and prenatal diagnosis for patients with MPS
disorders and also aids in designing of newer therapeutics
for efficient treatment. It also helps in establishment of
genotype-phenotype correlation and provision of better
genetic counselling to the families with MPS affected
members.
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